CASE REPORT ON MRS. T AGE 28 YEARS OLD P2A0 ACCEPTANCE OF CONTRACEPTION FOR 3 MONTHS WITH MENORRHAGIA AND MILD ANEMIA IN KEDUNGMUNDU PREMARY HEALTH CARE SEMARANG
Abstract
The main problem, the 3-month injectable contraceptive method has a percentage of side effects of menstrual
disorders (2.9%), based on a preliminary study at the Kedungmundu Premary Health Care, 3 months injectable
contraceptive acceptors (88.13%), experienced menstrual disorders (16.23%). One of the types of menstrual
disorders is menorrhagia and as many as (0.78%). Respondents experienced continuous menstruation for 26 days
and were often weak and lethargic. The problem in this case is Mrs. T, age 28 years P2A0, acceptor of 3-month
injectable contraception with menorrhagia with mild anemia. Destination, for administering the 3 Months
Injectable Contraceptive KB Acceptor with menorrhagia at the Kedungmundu Health Center. The scope is, the 3
month injection contraceptive acceptor with menorrhagia in the working area of the Kedungmundu Public Health
Center. The method used is descriptive method, the type of final project report is a case study. The results after
being given combined oral pill therapy, is a treatment for menorrhagia due to progesterone contraception, so that
menorrhagia becomes significantly decreased and the menstrual cycle returns to normal, while in mild anemia, Fe
tablets are given and recommend foods containing iron so that the first Hb level is 10.5 g /Dl categorized as mild
anemia rose to 12 g/dL and was not anemic.
Keywords: Contraception, DMPA, Menorrhagia.
disorders (2.9%), based on a preliminary study at the Kedungmundu Premary Health Care, 3 months injectable
contraceptive acceptors (88.13%), experienced menstrual disorders (16.23%). One of the types of menstrual
disorders is menorrhagia and as many as (0.78%). Respondents experienced continuous menstruation for 26 days
and were often weak and lethargic. The problem in this case is Mrs. T, age 28 years P2A0, acceptor of 3-month
injectable contraception with menorrhagia with mild anemia. Destination, for administering the 3 Months
Injectable Contraceptive KB Acceptor with menorrhagia at the Kedungmundu Health Center. The scope is, the 3
month injection contraceptive acceptor with menorrhagia in the working area of the Kedungmundu Public Health
Center. The method used is descriptive method, the type of final project report is a case study. The results after
being given combined oral pill therapy, is a treatment for menorrhagia due to progesterone contraception, so that
menorrhagia becomes significantly decreased and the menstrual cycle returns to normal, while in mild anemia, Fe
tablets are given and recommend foods containing iron so that the first Hb level is 10.5 g /Dl categorized as mild
anemia rose to 12 g/dL and was not anemic.
Keywords: Contraception, DMPA, Menorrhagia.
Full Text:
PDFRefbacks
- There are currently no refbacks.